Fundz

AB Science successfully completes a EUR 2.8 million private placement to finance its ongoing activities, particularly focusing on the clinical development of the AB8939 program.

PRIVATEOct 17, 2025

Amount Raised

€2.8 Million

Round Type

Post-IPO Equity

ParisBiotechnology

Description

AB Science S.A. announces the successful completion of a capital increase of EUR 2.8 million. This funding is intended to support the clinical development of the AB8939 program in AML. The company will utilize the proceeds to finish phase 1 and launch an expansion study

Quick answer

AB Science raised €2.8 Million in a Post-IPO Equity round, dated October 17, 2025. AB Science is based in Paris, Ile-de-France, France.

How much did AB Science raise?
AB Science raised €2.8 Million in a Post-IPO Equity round on October 17, 2025.
What does AB Science do?
AB Science S.A. is a biopharmaceutical company specializing in the research and development of innovative therapies for various diseases.
Where is AB Science based and how big is it?
AB Science is based in Paris, Ile-de-France, France.
Who are the decision-makers at AB Science?
Fundz holds 1 contact at AB Science. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as AB Science that raised within 45 days of this round, from Fundz verified event records.

  • Circular Genomics raised $15M (Series A) on December 1, 2025.
  • Protego Biopharma raised $130M (Series B) on December 1, 2025.
  • Rology raised an undisclosed amount (Funding Round) on December 1, 2025.
  • Fremantle Seaweed raised $1.7M (Seed) on December 1, 2025.
  • Morphocell Technologies raised $50M (Series A) on December 1, 2025.
  • Santersus AG raised an undisclosed amount (Series A) on December 1, 2025.

Who to call at AB Science, and when

A new round usually means AB Science is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day AB Science raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at AB Science, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at AB Science. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

AB Science

Location

Paris, Ile-de-France, France

About

AB Science S.A. is a biopharmaceutical company specializing in the research and development of innovative therapies for various diseases. The company is focused on providing solutions for serious medical conditions, primarily in oncology and neurodegenerative disorders. AB Science's lead program, AB8939, is aimed at treating acute myeloid leukemia (AML). With strong financial backing, the company is poised to advance its clinical development programs in the coming years.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment AB Science raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for AB Science's next move

See what Strategic adds

AB Science raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.